CollPlant rises as AbbVie partnership helps it turn a profit

Collplant Biotechnologies

24/03/2022 13:06

** Drug developer's  CLGN.O  shares up 4.7% at $12.96
premarket 
    ** Co reports 2021 profit of $237,000, versus a loss of $5.8
million in 2020, helped by an upfront payment by AbbVie  ABBV.N 
as part of a collaboration deal signed in February 2021
 urn:newsml:reuters.com:*:nPn1fSWhWa
    ** Co says it plans to begin a large animal study for its 3D
bio-printed regenerative breast implants
    ** CLGN shares down ~24% YTD 

 (Reporting by Manas Mishra)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15))